000097467 001__ 97467 000097467 005__ 20210902121849.0 000097467 0247_ $$2doi$$a10.3390/cancers12113341 000097467 0248_ $$2sideral$$a121710 000097467 037__ $$aART-2020-121710 000097467 041__ $$aeng 000097467 100__ $$aJuarranz, Á. 000097467 245__ $$aPhotodynamic therapy (PDT) in oncology 000097467 260__ $$c2020 000097467 5060_ $$aAccess copy available to the general public$$fUnrestricted 000097467 5203_ $$aThe issue is focused on Photodynamic Therapy (PDT), which is a minimally invasive therapeutic modality approved for treatment of several types of cancer and non-oncological disorders. PDT is being used in dermatology for the treatment of non-melanoma skin cancers (basal cell carcinoma, BCC, and Bowen disease, BD) and precancerous lesions (actinic keratosis, AKs), among other tumors such as: head and neck cancer and bladder and gynaecological neoplasms. PDT can also be used for cancer diagnosis by means of theragnosis (a term arising from the combination of diagnostic tests and therapy), a promising technique based on targeted fluorescent imaging and PDT. Photofrin and aminolevulinic acid and its ester derivatives are the main compounds used in clinical trials although newer photosensitizers (PSs) and delivery tools are being evaluated. This Special Issue on Cancers includes original articles on photochemical mechanisms, new PSs and delivery tools, cellular and tissue targets, cellular response (cell death or survival), vascular damage and immune response. We hope all the articles published in this Special Issue can help to improve this therapeutic cancer modality. 000097467 536__ $$9info:eu-repo/grantAgreement/ES/MINECO-ISCIII-FEDER/FIS PI15-00974$$9info:eu-repo/grantAgreement/ES/MINECO-ISCIII-FEDER/FIS PI18-00708 000097467 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttp://creativecommons.org/licenses/by/3.0/es/ 000097467 590__ $$a6.639$$b2020 000097467 591__ $$aONCOLOGY$$b51 / 242 = 0.211$$c2020$$dQ1$$eT1 000097467 592__ $$a1.818$$b2020 000097467 593__ $$aOncology$$c2020$$dQ1 000097467 593__ $$aCancer Research$$c2020$$dQ1 000097467 655_4 $$ainfo:eu-repo/semantics/other$$vinfo:eu-repo/semantics/publishedVersion 000097467 700__ $$0(orcid)0000-0001-8034-3617$$aGilaberte, Y.$$uUniversidad de Zaragoza 000097467 700__ $$aGonzález, S. 000097467 7102_ $$11007$$2183$$aUniversidad de Zaragoza$$bDpto. Medicina, Psiqu. y Derm.$$cÁrea Dermatología 000097467 773__ $$g12, 11 (2020), 3341 [1-5]$$pCancers$$tCancers$$x2072-6694 000097467 8564_ $$s165014$$uhttps://zaguan.unizar.es/record/97467/files/texto_completo.pdf$$yVersión publicada 000097467 8564_ $$s530394$$uhttps://zaguan.unizar.es/record/97467/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada 000097467 909CO $$ooai:zaguan.unizar.es:97467$$particulos$$pdriver 000097467 951__ $$a2021-09-02-10:29:10 000097467 980__ $$aARTICLE